Abbott Laboratories (ABT)
USD 111.93
(-1.2%)
USD 111.93
(-1.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.71 Billion USD | -3.05% |
| 2022 | 16.14 Billion USD | 0.22% |
| 2021 | 16.11 Billion USD | 13.09% |
| 2020 | 14.24 Billion USD | 0.76% |
| 2019 | 14.14 Billion USD | -0.57% |
| 2018 | 14.22 Billion USD | 6.72% |
| 2017 | 13.32 Billion USD | 54.18% |
| 2016 | 8.64 Billion USD | -1.67% |
| 2015 | 8.79 Billion USD | 4.28% |
| 2014 | 8.43 Billion USD | -8.16% |
| 2013 | 9.17 Billion USD | -43.97% |
| 2012 | 16.38 Billion USD | -6.7% |
| 2011 | 17.55 Billion USD | 24.52% |
| 2010 | 14.1 Billion USD | 26.47% |
| 2009 | 11.15 Billion USD | 0.23% |
| 2008 | 11.12 Billion USD | 12.21% |
| 2007 | 9.91 Billion USD | 15.21% |
| 2006 | 8.6 Billion USD | 17.6% |
| 2005 | 7.31 Billion USD | 10.56% |
| 2004 | 6.61 Billion USD | -2.44% |
| 2003 | 6.78 Billion USD | 22.45% |
| 2002 | 5.54 Billion USD | 4.29% |
| 2001 | 5.31 Billion USD | 29.36% |
| 2000 | 4.1 Billion USD | 1.37% |
| 1999 | 4.05 Billion USD | 2.16% |
| 1998 | 3.96 Billion USD | -0.55% |
| 1997 | 3.98 Billion USD | 8.81% |
| 1996 | 3.66 Billion USD | 10.93% |
| 1995 | 3.3 Billion USD | 9.46% |
| 1994 | 3.01 Billion USD | 7.82% |
| 1993 | 2.79 Billion USD | -13.83% |
| 1992 | 3.24 Billion USD | 26.96% |
| 1991 | 2.55 Billion USD | 16.38% |
| 1990 | 2.19 Billion USD | 15.14% |
| 1989 | 1.9 Billion USD | 8.93% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.08 Billion USD | -0.24% |
| 2024 Q1 | 4.09 Billion USD | 20.62% |
| 2024 Q3 | 4.07 Billion USD | -0.15% |
| 2023 Q2 | 3.79 Billion USD | -0.55% |
| 2023 Q4 | 3.39 Billion USD | -10.64% |
| 2023 Q3 | 3.79 Billion USD | 0.0% |
| 2023 FY | 15.65 Billion USD | -3.05% |
| 2023 Q1 | 3.81 Billion USD | -8.94% |
| 2022 FY | 16.14 Billion USD | 0.22% |
| 2022 Q1 | 3.99 Billion USD | -7.59% |
| 2022 Q2 | 3.94 Billion USD | -1.2% |
| 2022 Q3 | 4.01 Billion USD | 1.6% |
| 2022 Q4 | 4.19 Billion USD | 4.56% |
| 2021 Q4 | 4.32 Billion USD | 9.22% |
| 2021 FY | 16.11 Billion USD | 13.09% |
| 2021 Q2 | 3.88 Billion USD | -1.57% |
| 2021 Q1 | 3.94 Billion USD | 4.5% |
| 2021 Q3 | 3.95 Billion USD | 1.93% |
| 2020 Q3 | 3.39 Billion USD | -0.03% |
| 2020 Q1 | 3.68 Billion USD | 5.61% |
| 2020 FY | 14.24 Billion USD | 0.76% |
| 2020 Q4 | 3.77 Billion USD | 11.32% |
| 2020 Q2 | 3.39 Billion USD | -7.97% |
| 2019 Q2 | 3.49 Billion USD | -3.91% |
| 2019 Q4 | 3.49 Billion USD | -0.82% |
| 2019 FY | 14.14 Billion USD | -0.57% |
| 2019 Q1 | 3.63 Billion USD | 6.66% |
| 2019 Q3 | 3.52 Billion USD | 0.74% |
| 2018 FY | 14.22 Billion USD | 6.72% |
| 2018 Q1 | 3.71 Billion USD | 2.2% |
| 2018 Q2 | 3.6 Billion USD | -3.01% |
| 2018 Q4 | 3.4 Billion USD | -2.46% |
| 2018 Q3 | 3.49 Billion USD | -3.0% |
| 2017 Q3 | 3.16 Billion USD | 4.12% |
| 2017 Q1 | 3.49 Billion USD | 68.5% |
| 2017 Q2 | 3.03 Billion USD | -13.05% |
| 2017 Q4 | 3.63 Billion USD | 14.96% |
| 2017 FY | 13.32 Billion USD | 54.18% |
| 2016 Q1 | 2.22 Billion USD | 2.49% |
| 2016 FY | 8.64 Billion USD | -1.67% |
| 2016 Q3 | 2.12 Billion USD | -4.93% |
| 2016 Q4 | 2.07 Billion USD | -2.22% |
| 2016 Q2 | 2.23 Billion USD | 0.41% |
| 2015 FY | 8.79 Billion USD | 4.28% |
| 2015 Q4 | 2.16 Billion USD | -1.28% |
| 2015 Q2 | 2.22 Billion USD | 0.77% |
| 2015 Q3 | 2.19 Billion USD | -1.26% |
| 2015 Q1 | 2.2 Billion USD | 0.73% |
| 2014 Q2 | 2.28 Billion USD | -1.68% |
| 2014 FY | 8.43 Billion USD | -8.16% |
| 2014 Q3 | 2.04 Billion USD | -10.6% |
| 2014 Q1 | 2.32 Billion USD | 1.66% |
| 2014 Q4 | 2.19 Billion USD | 7.25% |
| 2013 Q1 | 2.33 Billion USD | -46.22% |
| 2013 FY | 9.17 Billion USD | -43.97% |
| 2013 Q4 | 2.28 Billion USD | -0.17% |
| 2013 Q3 | 2.28 Billion USD | 0.66% |
| 2013 Q2 | 2.27 Billion USD | -2.45% |
| 2012 Q4 | 4.33 Billion USD | 6.07% |
| 2012 FY | 16.38 Billion USD | -6.7% |
| 2012 Q1 | 4 Billion USD | -1.26% |
| 2012 Q2 | 3.95 Billion USD | -1.25% |
| 2012 Q3 | 4.08 Billion USD | 3.29% |
| 2011 Q2 | 3.8 Billion USD | 0.5% |
| 2011 Q3 | 5.24 Billion USD | 38.13% |
| 2011 Q4 | 4.05 Billion USD | -22.71% |
| 2011 FY | 17.55 Billion USD | 24.52% |
| 2011 Q1 | 3.78 Billion USD | -7.62% |
| 2010 Q3 | 3.75 Billion USD | 4.19% |
| 2010 FY | 14.1 Billion USD | 26.47% |
| 2010 Q1 | 2.89 Billion USD | -2.69% |
| 2010 Q2 | 3.6 Billion USD | 24.52% |
| 2010 Q4 | 4.09 Billion USD | 9.08% |
| 2009 FY | 11.15 Billion USD | 0.23% |
| 2009 Q3 | 2.76 Billion USD | 2.45% |
| 2009 Q4 | 2.97 Billion USD | 7.65% |
| 2009 Q1 | 2.72 Billion USD | -10.15% |
| 2009 Q2 | 2.69 Billion USD | -0.98% |
| 2008 Q3 | 2.74 Billion USD | 1.44% |
| 2008 FY | 11.12 Billion USD | 12.21% |
| 2008 Q4 | 3.02 Billion USD | 10.21% |
| 2008 Q2 | 2.7 Billion USD | 2.7% |
| 2008 Q1 | 2.63 Billion USD | 3.79% |
| 2007 Q2 | 2.37 Billion USD | 6.47% |
| 2007 Q1 | 2.23 Billion USD | -2.78% |
| 2007 Q4 | 2.54 Billion USD | -1.72% |
| 2007 FY | 9.91 Billion USD | 15.21% |
| 2007 Q3 | 2.58 Billion USD | 8.66% |
| 2006 Q4 | 2.29 Billion USD | 0.87% |
| 2006 Q3 | 2.27 Billion USD | -11.3% |
| 2006 FY | 8.6 Billion USD | 17.6% |
| 2006 Q2 | 2.56 Billion USD | 31.81% |
| 2006 Q1 | 1.94 Billion USD | 0.65% |
| 2005 Q3 | 1.85 Billion USD | 3.45% |
| 2005 Q1 | 1.72 Billion USD | -6.85% |
| 2005 FY | 7.31 Billion USD | 10.56% |
| 2005 Q4 | 1.93 Billion USD | 4.19% |
| 2005 Q2 | 1.79 Billion USD | 4.22% |
| 2004 Q3 | 1.53 Billion USD | -8.23% |
| 2004 Q1 | 1.64 Billion USD | -6.96% |
| 2004 Q2 | 1.67 Billion USD | 1.83% |
| 2004 Q4 | 1.85 Billion USD | 20.51% |
| 2004 FY | 6.61 Billion USD | -2.44% |
| 2003 Q1 | 1.4 Billion USD | -10.93% |
| 2003 Q2 | 2.08 Billion USD | 48.95% |
| 2003 Q3 | 1.52 Billion USD | -26.9% |
| 2003 Q4 | 1.76 Billion USD | 15.71% |
| 2003 FY | 6.78 Billion USD | 22.45% |
| 2002 Q1 | 1.24 Billion USD | -17.1% |
| 2002 Q4 | 1.57 Billion USD | 15.73% |
| 2002 FY | 5.54 Billion USD | 4.29% |
| 2002 Q3 | 1.36 Billion USD | 0.21% |
| 2002 Q2 | 1.35 Billion USD | 8.74% |
| 2001 Q2 | 1.34 Billion USD | 26.31% |
| 2001 Q3 | 1.39 Billion USD | 3.72% |
| 2001 Q4 | 1.5 Billion USD | 7.9% |
| 2001 FY | 5.31 Billion USD | 29.36% |
| 2001 Q1 | 1.06 Billion USD | -1.85% |
| 2000 Q1 | 1 Billion USD | -11.89% |
| 2000 Q2 | 998.33 Million USD | -0.7% |
| 2000 Q3 | 1.01 Billion USD | 1.94% |
| 2000 Q4 | 1.08 Billion USD | 6.65% |
| 2000 FY | 4.1 Billion USD | 1.37% |
| 1999 Q2 | 1 Billion USD | 5.83% |
| 1999 Q4 | 1.14 Billion USD | 18.88% |
| 1999 Q1 | 947.45 Million USD | -10.35% |
| 1999 FY | 4.05 Billion USD | 2.16% |
| 1999 Q3 | 959.87 Million USD | -4.27% |
| 1998 Q4 | 1.05 Billion USD | 10.4% |
| 1998 FY | 3.96 Billion USD | -0.55% |
| 1998 Q3 | 957.28 Million USD | -3.24% |
| 1998 Q2 | 989.29 Million USD | 2.83% |
| 1998 Q1 | 962.05 Million USD | -10.73% |
| 1997 Q3 | 1 Billion USD | 3.16% |
| 1997 Q4 | 1.07 Billion USD | 7.57% |
| 1997 FY | 3.98 Billion USD | 8.81% |
| 1997 Q1 | 936.67 Million USD | -8.66% |
| 1997 Q2 | 971.15 Million USD | 3.68% |
| 1996 Q3 | 894.23 Million USD | -1.05% |
| 1996 FY | 3.66 Billion USD | 10.93% |
| 1996 Q1 | 840.96 Million USD | -2.24% |
| 1996 Q2 | 903.71 Million USD | 7.46% |
| 1996 Q4 | 1.02 Billion USD | 14.68% |
| 1995 FY | 3.3 Billion USD | 9.46% |
| 1995 Q4 | 860.25 Million USD | 10.63% |
| 1995 Q2 | 819.63 Million USD | -3.12% |
| 1995 Q1 | 846 Million USD | 2.51% |
| 1995 Q3 | 777.58 Million USD | -5.13% |
| 1994 Q2 | 713.72 Million USD | -1.42% |
| 1994 Q3 | 754.95 Million USD | 5.78% |
| 1994 Q4 | 825.3 Million USD | 9.32% |
| 1994 FY | 3.01 Billion USD | 7.82% |
| 1994 Q1 | 723.98 Million USD | 149.43% |
| 1993 Q4 | 290.25 Million USD | -64.72% |
| 1993 FY | 2.79 Billion USD | -13.83% |
| 1993 Q2 | 899.9 Million USD | 14.46% |
| 1993 Q1 | 786.2 Million USD | -4.06% |
| 1993 Q3 | 822.8 Million USD | -8.57% |
| 1992 Q3 | 744.4 Million USD | -21.77% |
| 1992 Q2 | 951.6 Million USD | 29.84% |
| 1992 Q4 | 819.5 Million USD | 10.09% |
| 1992 Q1 | 732.9 Million USD | 7.32% |
| 1992 FY | 3.24 Billion USD | 26.96% |
| 1991 Q4 | 682.9 Million USD | 8.69% |
| 1991 FY | 2.55 Billion USD | 16.38% |
| 1991 Q2 | 631.7 Million USD | 2.6% |
| 1991 Q3 | 628.3 Million USD | -0.54% |
| 1991 Q1 | 615.7 Million USD | 3.65% |
| 1990 Q4 | 594 Million USD | 8.57% |
| 1990 FY | 2.19 Billion USD | 15.14% |
| 1990 Q3 | 547.1 Million USD | 0.72% |
| 1990 Q2 | 543.2 Million USD | 5.64% |
| 1990 Q1 | 514.2 Million USD | 112.36% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q4 | -4.15 Billion USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | 1.9 Billion USD | 8.93% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Allurion Technologies Inc. | 120.57 Million USD | -12930.894% |
| Artivion, Inc. | 223.43 Million USD | -6932.054% |
| Avanos Medical, Inc. | 375.5 Million USD | -4084.288% |
| Butterfly Network, Inc. | 162.46 Million USD | -9570.947% |
| Butterfly Network, Inc. | 162.46 Million USD | -9570.947% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -1399.881% |
| Boston Scientific Corporation | 7.47 Billion USD | -110.11% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -90064.123% |
| CONMED Corporation | 564.24 Million USD | -2684.621% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | -408.331% |
| Paragon 28, Inc. | 210.1 Million USD | -7378.344% |
| Glaukos Corporation | 367.83 Million USD | -4171.469% |
| Globus Medical, Inc. | 887.16 Million USD | -1671.045% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | -2663.793% |
| Integer Holdings Corporation | 250.95 Million USD | -6160.784% |
| Medtronic plc | 16.12 Billion USD | 2.585% |
| Nevro Corp. | 389.36 Million USD | -3935.257% |
| Owlet, Inc. | 51.21 Million USD | -30576.116% |
| Penumbra, Inc. | 590.87 Million USD | -2559.098% |
| Vicarious Surgical Inc. | 80.66 Million USD | -19377.847% |
| Smith & Nephew plc | 3.46 Billion USD | -353.187% |
| Sonendo, Inc. | 68.46 Million USD | -22848.952% |
| STERIS plc | 1.4 Billion USD | -1021.996% |
| Stryker Corporation | 9.2 Billion USD | -70.616% |
| Vapotherm, Inc. | 66.02 Million USD | -23697.047% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | -379.609% |